Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension

Fig. 3

Eplerenone has no direct effect on pressure overload-induced structural RV remodeling. Pharmacological aldosterone antagonism with Eplerenone had no effect on RV total collagen content assessed by picrosirius red stains (percentage of the total RV; A), Col1A1 (percentage of sham; B) and Col3A1 gene expression (percentage of sham; C) Eplerenone did not affect cardiomyocyte hypertrophy (CM diameter, μm; D), ANP (E) or BNP gene expression (percentage of sham; F). n = 4–5 mice per group; *p < 0.05 vs. cntrl

Back to article page